Sobel Alan D. 4
4 · Cytosorbents Corp · Filed Aug 12, 2022
Insider Transaction Report
Form 4
Sobel Alan D.
Director
Transactions
- Award
Stock Option (right to buy)
2022-08-10+18,975→ 18,975 totalExercise: $1.95Exp: 2032-08-10→ Common Stock (18,975 underlying)
Holdings
- 79,300
Common Stock
- 2,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015 and (ii) 10,000 shares of common stock owned directly by the reporting person.
- [F2]These shares are held in the Bernard Sobel Revocable Trust (the "Trust"), for which the reporting person is a trustee and a named beneficiary. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.
- [F3]The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four equal parts on 8/10/2022, 9/30/2022, 12/31/2022 and 3/31/2023, subject to the reporting person's continued service as of the applicable vesting date.